Press Releases

Press Releases

Filters
Viatris Inc. to Release First Quarter 2021 Financial Results on May 10, 2021
Viatris Inc. and Kindeva Drug Delivery Announce FDA Tentative Approval of the First Abbreviated New Drug Application Generic Version of Symbicort® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol
Viatris Inc. to Participate in Barclays Global Healthcare Conference
Viatris Inc. Hosts Inaugural Investor Day Outlining Unique and Differentiated Business Model, High-Quality Operational Platform, and Focus on CSR and Financial Commitments
Viatris Inc. Announces 2021 Financial Guidance and Reaffirms Strategic and Financial Commitments
Viatris Inc. to Hold Conference Call on Monday, Feb. 22, 2021, to Discuss 2021 Financial Guidance
Mylan Wins Summary Judgment in EpiPen® Litigation Brought by Sanofi
Viatris Inc. Recommends Caution on TRC Capital Corp.'s Attempt to Acquire Shares at a Significant Discount via Mini-Tender Offer
Viatris Inc. Announces Additional Details of Previously Disclosed Global Restructuring Initiative
Viatris Inc. to Present at the J.P. Morgan 39th Annual Healthcare Conference January 14, 2021 and Will Host its Inaugural Investor Day March 1, 2021
Displaying 1 - 10 of 13